HTG Molecular Diagnostics
HTGM
#10559
Rank
$1.06 M
Marketcap
$0.48
Share price
0.00%
Change (1 day)
-96.26%
Change (1 year)

Operating Margin for HTG Molecular Diagnostics (HTGM)

Operating Margin as of December 2025 (TTM): -326.08%

According to HTG Molecular Diagnostics 's latest financial reports and stock price the company's current Operating Margin is -326.08%. At the end of 2021 the company had an Operating Margin of -192.24%.

Operating Margin history for HTG Molecular Diagnostics from 2014 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2021-192.24%-21.2%
2020-243.96%142.82%
2019-100.47%31.33%
2018-76.50%-40.44%
2017-128.44%-74.67%
2016-507.13%-4.17%
2015-529.19%26.21%
2014-419.30%-20.09%
2013-524.70%1.9%
2012-514.91%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Affimed
AFMD
-7,951.20% 2,338.42%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Calithera Biosciences
CALA
-1,180.38% 261.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-96.77%-70.32%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.